Ashish Bedi, MD
Vascular Surgery · Marlton, NJNPI 1528261443
Payments from drug & device makers
Across 106 payments — averaging $59.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inari Medical, Inc.$957
- Medtronic$865
- Penumbra, Inc.$603
- W. L. Gore & Associates, Inc.$500
- Cook Medical LLC$461
- Stryker$435
- plus $2K from 25 others
What the payments were for
- Travel & lodging$160%
- Food & beverage$6,300100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inari Medical, Inc. | 16 | $957 |
| Medtronic(2 entities) | 9 | $865 |
| Penumbra, Inc. | 7 | $603 |
| W. L. Gore & Associates, Inc. | 9 | $500 |
| Cook Medical LLC | 6 | $461 |
| Stryker | 6 | $435 |
| Smith+Nephew | 10 | $399 |
| Boston Scientific | 3 | $305 |
| Silk Road Medical, Inc. | 2 | $300 |
| Avinger Inc. | 2 | $222 |
| Bard Peripheral Vascular, Inc. | 7 | $213 |
| Angiodynamics, Inc. | 3 | $180 |
| Lemaitre Vascular, Inc. | 2 | $128 |
| Baxter Healthcare | 1 | $118 |
| Lifenet Health | 1 | $103 |
| Getinge USA Sales, LLC | 2 | $96 |
| Tactile Systems Technology Inc | 3 | $70 |
| Standard Bariatrics, Inc. | 1 | $53 |
| Koya Medical, Inc. | 2 | $38 |
| Johnson & Johnson | 2 | $36 |
| Davol Inc. | 1 | $30 |
| Cashflow Solutions, LLC | 2 | $26 |
| KCI USA, Inc. | 1 | $25 |
| Terumo Medical Corporation | 1 | $25 |
| Siemens Medical Solutions USA, Inc. | 1 | $24 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $23 |
| Acera Surgical, Inc. | 1 | $21 |
| Solventum Corporation | 1 | $18 |
| Biocomposites Inc | 1 | $16 |
| GSK | 1 | $14 |
| Pfizer | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLOWTRIEVER CATHETER, S$556
- CT THROMBECTOMY SYSTEM KIT$556
- ENDURANT IIS$445
- ENROUTE Transcarotid Stent$300
- ENROUTE Transcarotid Neuroprotection System$300
- Indigo$250
- Cook Medical AAA$243
- GORE EXCLUDER Iliac Branch Endoprosthesis$239
- ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter$177
- Zenith Alpha$174
- GORE EXCLUDER Thoracoabdominal Branch Endoprosthesis$169
- ENHANCE Transcarotid Peripheral Access Kit$150
- ENROUTE .014 Guidewire$150
- Endurant$145
- Auryon Laser System 100-120 Vac$142
- ARTIX MT$139
- PANTHERIS$134
- Penumbra System$127
- Indigo System$125
- Stravix$121
How this compares
$6,316 in reported general payments places this provider in the 50th percentile of 182 vascular surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 85 | $53,800 |
| XareltoRivaroxaban | 33 | $21,148 |
| ClopidogrelClopidogrel Bisulfate | 67 | $783 |
| Cilostazol | 16 | $287 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 26 | $217 |
| Atorvastatin Calcium | 21 | $99 |
| Tramadol Hcl | 12 | $20 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $13 | $53,80085 claims |
| Johnson & JohnsonXarelto | $36 | $21,14833 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 182 vascular surgery providers in New Jersey.
Other vascular surgery in Marlton
- David O'ConnorHackensack$894K
- Steven EliasEnglewood$708K
- Michael WildermanHackensack$386K
- Joseph LombardiPomona$321K
- William BeckermanNew Brunswick$176K
- Neil PoulsenRockaway$148K
- Massimo NapolitanoWayne$147K
- Saum RahimiNew Brunswick$101K
- Laurel HastingsCamden$98K
- Danielle PinedaPomona$97K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.